A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers-Reference-Cited by-同舟云学术

A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers

Published:2019-03-29 Issue:5 Volume:60 Page:958-967
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Finnema Sjoerd J.¹^ORCID,Rossano Samantha¹²,Naganawa Mika¹,Henry Shannan¹,Gao Hong¹,Pracitto Richard¹,Maguire Ralph P.³,Mercier Joël³,Kervyn Sophie³,Nicolas Jean‐Marie³,Klitgaard Henrik³,DeBruyn Steven³,Otoul Christian³,Martin Paul³,Muglia Pierandrea³,Matuskey David¹,Nabulsi Nabeel B.¹,Huang Yiyun¹,Kaminski Rafal M.³,Hannestad Jonas³,Stockis Armel³,Carson Richard E.¹²

Affiliation:

1. Department of Radiology and Biomedical ImagingPositron Emission Tomography CenterYale University New Haven Connecticut

2. Department of Biomedical EngineeringYale University New Haven Connecticut

3. UCB Pharma Braine‐l'Alleud Belgium

Funder

UCB Pharma, National Center for Advancing Translational Sciences

Vetenskapsrådet

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link